当前位置:首页 - 行情中心 - 欧康医药(920230) - 财务分析 - 现金流量表

欧康医药

(920230)

  

流通市值:5.81亿  总市值:12.38亿
流通股本:4724.78万   总股本:1.01亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金92,294,208.24342,454,164.74259,115,711.46170,472,258.22
  收到的税费返还1,434,782.527,289,050.713,799,165.511,600,753.06
  收到其他与经营活动有关的现金1,188,329.584,766,582.284,225,521.12,912,458.39
  经营活动现金流入小计94,917,320.34354,509,797.73267,140,398.07174,985,469.67
  购买商品、接受劳务支付的现金57,185,313.94299,155,453.38235,045,144.04135,011,363.26
  支付给职工以及为职工支付的现金7,859,130.0822,986,026.2815,288,466.2210,978,754.9
  支付的各项税费1,035,435.254,822,4203,416,280.12,743,230.73
  支付其他与经营活动有关的现金1,357,482.7320,547,010.779,908,693.073,479,716.36
  经营活动现金流出小计67,437,362347,510,910.43263,658,583.43152,213,065.25
  经营活动产生的现金流量净额27,479,958.346,998,887.33,481,814.6422,772,404.42
二、投资活动产生的现金流量:
  收回投资收到的现金11,183,657186,734,488.8289,174,936.8270,824,474.57
  取得投资收益收到的现金8,303.85944,990.9418,875.916,650.4
  处置固定资产、无形资产和其他长期资产收回的现金净额17,851.08130,567117,476.5107,963.72
  收到的其他与投资活动有关的现金--20,000-
  投资活动现金流入小计11,209,811.93187,810,046.7289,731,289.2270,949,088.69
  购建固定资产、无形资产和其他长期资产支付的现金5,769,708.0627,370,17017,826,320.0813,316,754.51
  投资支付的现金30,190,000177,806,91582,336,91566,456,915
  投资活动现金流出小计35,959,708.06205,177,085100,163,235.0879,773,669.51
  投资活动产生的现金流量净额-24,749,896.13-17,367,038.28-10,431,945.86-8,824,580.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,101,6001,101,600-
  取得借款收到的现金1,000,00021,000,00011,000,00011,000,000
  收到其他与筹资活动有关的现金-102,986.8--
  筹资活动现金流入小计1,000,00022,204,586.812,101,60011,000,000
  偿还债务支付的现金-20,000,00010,000,00010,000,000
  分配股利、利润或偿付利息支付的现金143,472.228,352,460.548,201,956.368,047,313.74
  支付其他与筹资活动有关的现金-549,135.46262,577.17152,941.43
  筹资活动现金流出小计143,472.2228,901,59618,464,533.5318,200,255.17
  筹资活动产生的现金流量净额856,527.78-6,697,009.2-6,362,933.53-7,200,255.17
四、汇率变动对现金及现金等价物的影响-269,724.71-115,822.79-51,143.591,949.47
五、现金及现金等价物净增加额3,316,865.28-17,180,982.97-13,364,208.346,749,517.9
  加:期初现金及现金等价物余额5,630,407.7322,811,390.722,811,390.722,811,390.7
  期末现金及现金等价物余额8,947,273.015,630,407.739,447,182.3629,560,908.6
补充资料:
  净利润-11,435,251.17-2,867,815.24
  资产减值准备-3,791,435.11--34,835.62
  固定资产和投资性房地产折旧-20,430,537.62-9,586,496.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-20,430,537.62-9,586,496.51
  无形资产摊销-639,557-334,803.2
  处置固定资产、无形资产和其他长期资产的损失-975,561.19-3,090.12
  公允价值变动损失--32,327.74--306,720.1
  财务费用-776,951.73-314,758.06
  投资损失--526,165.91--43,208.56
  递延所得税-78,684.84-147,551.29
  其中:递延所得税资产减少-78,684.84-147,551.29
  存货的减少--10,226,179.99-3,476,576.62
  经营性应收项目的减少--23,369,924.78-30,112,775.47
  经营性应付项目的增加--3,365,765.85--25,718,967.31
  其他-5,349,153.08-1,833,256.58
  不涉及现金收支的投资和筹资活动金额其他项目-390,402.54-787,662.57
  现金的期末余额-5,630,407.73-29,564,912.17
  减:现金的期初余额-22,811,390.7-22,815,394.27
  现金及现金等价物的净增加额--17,180,982.97-6,749,517.9
公告日期2026-04-292026-04-152025-10-302025-08-27
审计意见(境内)标准无保留意见
TOP↑